Cogent Biosciences, Inc. · NASDAQ:COGT
Commodore Capital LP's stake in Cogent Biosciences, Inc. fell to 1.80% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Commodore Capital LP's stake in Cogent Biosciences, Inc. fell to 1.80%, 2,802,905 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 1.80%
- Shares
- 2,802,905
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 1.80% | 2,802,905 |
| Commodore Capital Master LP | 1.80% | 2,802,905 |
| Robert Egen Atkinson | 1.80% | 2,802,905 |
| Michael Kramarz | 1.80% | 2,802,905 |
Source
Related
- Cogent Biosciences, Inc.
- Commodore Capital LP
- Cogent Biosciences, Inc. shareholders
- Schedule 13G/A · Commodore Capital LP · Nov 14, 2025
- Schedule 13G/A · Commodore Capital LP · Aug 14, 2025
- Schedule 13G · Commodore Capital LP · Aug 14, 2025
- Form 4 · Morris Arlene · Aug 31, 2026
- Schedule 13G/A · Deerfield Mgmt, L.P. · Aug 13, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Robbins Andrew R · May 21, 2026